Trastuzumab in the Second-Line Treatment of HER2-Positive Metastatic Gastric Cancer. Experience of the Moscow Oncology Service. (2026). Voprosy Onkologii, 72(2), OF-2514. https://doi.org/10.37469/0507-3758-2026-72-2-OF-2514